MELK anticorps (AA 637-651)
Aperçu rapide pour MELK anticorps (AA 637-651) (ABIN1844288)
Antigène
Voir toutes MELK AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 637-651
-
Séquence
- C-VYKRLVEDIL SSCKV
-
Purification
- Purified antibody
-
Immunogène
- Synthesized peptide of human MELK (AA: 637-651:C-VYKRLVEDILSSCKV).
-
Isotype
- IgG2a
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS with 0.05 % sodium azide and 0.5 % protein stabilizer.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
-
- MELK (Maternal Embryonic Leucine Zipper Kinase (MELK))
-
Autre désignation
- MELK
-
Sujet
- Maternal embryonic leucine-zipper kinase (MELK) is a key regulator of survival of stemlike GBM cells in vitro. MELK expression is increased in breast cancer tissue and this increase is also associated with poor patient survival, as predicted for a candidate oncogene.
-
Poids moléculaire
- 74.6 kDa
-
ID gène
- 9833
-
UniProt
- Q14680
Antigène
-